Aardvark Therapeutics, Inc. (AARD)
NASDAQ: AARD · Real-Time Price · USD
5.59
+0.07 (1.27%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Aardvark Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | -57.59 | -20.59 | -7.21 | -13.56 |
| Depreciation & Amortization | 0.04 | 0.02 | - | 0.11 |
| Loss (Gain) From Sale of Investments | -1.3 | 0.12 | 1.22 | 2.32 |
| Stock-Based Compensation | 3.95 | 0.44 | 0.31 | 0.41 |
| Provision & Write-off of Bad Debts | - | 0.12 | 0.76 | 0.49 |
| Other Operating Activities | 0.38 | 0.24 | -0.83 | 1 |
| Change in Accounts Payable | 0.24 | 0.8 | 0.78 | 0.03 |
| Change in Other Net Operating Assets | 0.12 | 0.78 | -0.86 | -1.34 |
| Operating Cash Flow | -54.17 | -18.09 | -5.82 | -10.54 |
| Capital Expenditures | -0.1 | -0.11 | - | - |
| Investment in Securities | -49.57 | -11.89 | - | - |
| Other Investing Activities | - | - | - | -1 |
| Investing Cash Flow | -49.67 | -12 | - | -1 |
| Issuance of Common Stock | 91.64 | 0.33 | - | 0.23 |
| Other Financing Activities | -2.39 | -3.34 | - | - |
| Financing Cash Flow | 89.25 | 81.99 | - | 0.23 |
| Net Cash Flow | -14.59 | 51.91 | -5.82 | -11.32 |
| Free Cash Flow | -54.27 | -18.2 | -5.82 | -10.54 |
| Free Cash Flow Per Share | -2.77 | -4.55 | -1.47 | -2.71 |
| Levered Free Cash Flow | -31.18 | -10.67 | -3.54 | - |
| Unlevered Free Cash Flow | -31.18 | -10.67 | -3.54 | - |
| Change in Working Capital | 0.36 | 1.57 | -0.08 | -1.31 |
Source: S&P Capital IQ. Standard template.
Financial Sources.